Regulus Therapeutics (NASDAQ:RGLS)

CAPS Rating: 2 out of 5

Results 1 - 1 of 1

Recs

0
Member Avatar rknapton (< 20) Submitted: 8/22/2013 4:56:09 PM : Underperform Start Price: $9.51 RGLS Score: +46.15

Short. Biotech. High P/S ratio.

Results 1 - 1 of 1

Featured Broker Partners


Advertisement